Topic
pharmaceuticals
6 stories, newest first.
Business & Economy · United StatesAstraZeneca offers $10 billion for Rhythm Pharmaceuticals
AstraZeneca has made a non-binding offer of approximately $10 billion to acquire Rhythm Pharmaceuticals, a company specializing in treatments for rare forms of obesity. The offer values Rhythm at about $124 per share, including potential milestone payments.
United States2 min readTrust 53 · Craft 87 · Hype 15
Politics · United StatesTrump's Pharma Stock Holdings Grew After White House Return, Democrats Say
Investments in pharmaceutical companies on behalf of President Donald Trump reportedly increased substantially after his return to the White House. A report from congressional Democrats details a rise in stock holdings in firms that benefited from Medicare drug price negotiation exemptions.
United States4 min readTrust 60 · Craft 55 · Hype 45
Business & Economy · United StatesBayer to build $2.2bn Ohio plant creating 600 jobs
Bayer will invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, creating approximately 600 high-value jobs and 1,500 construction jobs. The facility is expected to be operational in phases starting in 2031.
United States3 min readTrust 60 · Craft 60 · Hype 20
Politics · United StatesFlorida sues Pfizer over COVID-19 vaccine marketing
Florida Attorney General James Uthmeier has filed a lawsuit against Pfizer, accusing the pharmaceutical company of deceptively marketing its COVID-19 vaccine. The suit claims Pfizer failed to disclose potential risks and seeks to halt alleged illegal actions, impose fines, and recover profits.
United States3 min readTrust 40 · Craft 50 · Hype 60
Politics · United StatesUS Treasury plans rules for China pharma deals
The U.S. Treasury Department is developing rules for biopharmaceutical companies investing in China. These regulations are expected to allow most licensing deals for drugs originating in China, with potential restrictions on weaponizable biotechnology or pathogens. The move aims to balance economic interests with national security concerns.
United States2 min readTrust 50 · Craft 45 · Hype 20
HealthModerna and Merck report melanoma vaccine trial success in phase three
Merck and Moderna announced positive phase three trial results for a personalised mRNA cancer vaccine combined with Keytruda, reducing melanoma recurrence and spread in high-risk patients. The treatment met its primary goal, with stock prices rising on the news. Further data will determine regulatory approval timelines.
4 min readTrust 85 · Craft 85 · Hype 15